Metformin and glitazones (i.e., pioglitazone), SGLT2 inhibitors and GLP-1 RA (* except for albiglutide) have demonstrated positive actions against AF, while sulfonylurea and insulin could induce deleterious effects. This evidence concerns the gene SLC5A2 and atrial fibrillation.